Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study
This study suggests that compared with DPP-4is, the use of GLP-1 RAs is linked to increased risks of certain autoimmune diseases. Careful monitoring might be required among patients on GLP-1 RAs.
Authors
- Ming‐Hsien Tsai (ORCID: https://orcid.org/0000-0003-3561-4689)
- Mon‐Ting Chen
- Young‐Ho Lee (ORCID: https://orcid.org/0000-0002-5749-1045)
- Yu‐Wei Fang (ORCID: https://orcid.org/0000-0002-1302-1885)
- Hung‐Hsiang Liou
- Tzu-Hao Li
Institutions
- Fu Jen Catholic University (TW)
- National Taipei University of Nursing and Health Science (TW)
- Jen-Ai Hospital (TW)
- Ministry of Health and Welfare (TW)
- Memorial Hospital (US)
Publication Details
- Journal
- Journal of Autoimmunity
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1016/j.jaut.2025.103453
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.18
Funders
- Shin Kong Wu Ho-Su Memorial Hospital